Effects of L-(adamant-2-yl)glycyl-L-alanyl-D-isoglutamine on the antitumor action of cyclophosphamide, 5-FU, cisplatin and dacarbazine on advanced carcinomas of the mouse. (CROSBI ID 518479)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Dašić, Gorana ; Pacor, S ; Bergamo, A. ; Salerno, G. ; Vranešić, Branka ; Jukić, Ruža ; Tomašić, Jelka ; Sava, Gianni
engleski
Effects of L-(adamant-2-yl)glycyl-L-alanyl-D-isoglutamine on the antitumor action of cyclophosphamide, 5-FU, cisplatin and dacarbazine on advanced carcinomas of the mouse.
Novel adamantyltripeptide L-(adamant-2-yl)glycyl-L-alanyl-D-isoglutamine (AdTP2) exhibits antitumor, antiviral and immunomodulatory properties. It was studied in comparison to peptidoglycan monomer (PGM) to test the effects of their use concomitant to that of anticancer cytotoxic drugs such as cyclophosphamide, 5-FU, cisplatin and dacarbazine. Lewis lung carcinoma and Ca mammary carcinoma in CBA mice were used as model systems.
L-(adamant-2-yl)glycyl-L-alanyl-D-isoglutamine; adamantyltripeptide; peptidoglycan monomer; antitumor activity; Ca mammary carcinoma; mice
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
Poster W2-8, p.2-x.
1994.
objavljeno
Podaci o matičnoj publikaciji
Periodicum Biologorum 96 (3), 1994 - Abstracts of Mechanisms in Local Immunity. 2nd Alps-Adria Immunology and Allergology Meeting, Opatija, 26.09.-28.09. 1994.
Podaci o skupu
2nd Alps-Adria Immunology and Allergology Meeting
poster
26.09.1994-28.09.1994
Opatija, Hrvatska
